•
Dec 31, 2020

Avidity Biosciences Q4 2020 Earnings Report

Total Revenue
$2.14M
Previous year: $1.45M
+48.2%
EPS
-$0.43
Previous year: -$0.503
-14.5%
Gross Profit
-$11.5M
Previous year: -$4.2M
+173.3%
Cash and Equivalents
$321M
Free Cash Flow
-$13.3M
Total Assets
$334M

Avidity Biosciences

Avidity Biosciences